Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-21 00:37 | 2022-01-18 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $241.94 | 5,675 | $1,372,991 | 405,229 |
| 2022-01-21 01:40 | 2022-01-18 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $247.80 | 8,000 | $1,982,400 | 17,175 |
| 2022-01-21 00:01 | 2022-01-10 | ECIA | ENCISION INC | FRIES ROBERT H | Director | BUY | $0.35 | 5,000 | $1,750 | 545,000 |
| 2022-01-21 02:08 | 2022-01-18 | TMCI | TREACE MEDICAL CONCEPTS, INC. | TREACE JAMES T | Director | SELL | $19.26 | 75,000 | $1,444,530 | 1,386,441 |
| 2022-01-21 01:35 | 2022-01-18 | DXCM | DEXCOM INC | SAYER KEVIN R | Director, Officer | SELL | $435.56 | 22,674 | $9,875,801 | 97,617 |
| 2022-01-19 20:52 | 2022-01-14 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, L.P. | BUY | $12.00 | 567,467 | $6,809,604 | 2,485,104 | |
| 2022-01-20 00:08 | 2022-01-15 | SIBN | SI-BONE, Inc. | Pisetsky Michael A | Officer | SELL | $22.00 | 400 | $8,801 | 118,263 |
| 2022-01-20 00:10 | 2022-01-18 | SIBN | SI-BONE, Inc. | RECUPERO ANTHONY J | Officer | SELL | $22.00 | 666 | $14,653 | 183,443 |
| 2022-01-20 00:09 | 2022-01-15 | SIBN | SI-BONE, Inc. | DUNN JEFFREY W | Director | SELL | $22.00 | 1,747 | $38,437 | 169,529 |
| 2022-01-19 02:54 | 2022-01-18 | IRMD | IRADIMED CORP | Susi Roger E. | Director, Officer, 10% owner | SELL | $41.21 | 10,000 | $412,056 | 772,950 |
| 2022-01-18 17:05 | 2022-01-14 | ATRC | AtriCure, Inc. | Austin Tonya | Officer | SELL | $66.11 | 2,719 | $179,753 | 22,830 |
| 2022-01-15 01:24 | 2022-01-12 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, L.P. | BUY | $12.50 | 5,000 | $62,500 | 1,917,637 | |
| 2022-01-14 00:06 | 2022-01-11 | IRMD | IRADIMED CORP | Susi Roger E. | Director, Officer, 10% owner | SELL | $44.54 | 10,000 | $445,379 | 782,950 |
| 2022-01-14 03:36 | 2022-01-11 | PEN | Penumbra Inc | Elsesser Adam | Director, Officer | OPT+S | $253.34 | 14,500 | $3,673,489 | 0 |
| 2022-01-13 04:01 | 2022-01-10 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Officer | OPT+S | $20.15 | 47,700 | $961,379 | 0 |
| 2022-01-13 01:25 | 2022-01-10 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, L.P. | BUY | $12.40 | 6,409 | $79,456 | 1,912,637 | |
| 2022-01-13 00:44 | 2022-01-12 | ANGO | Angiodynamics Inc. | Trowbridge Stephen A | Officer | BUY | $22.64 | 1,000 | $22,640 | 76,081 |
| 2022-01-13 00:35 | 2022-01-11 | ANGO | Angiodynamics Inc. | Clemmer James C | Director, Officer | BUY | $22.84 | 10,000 | $228,400 | 390,764 |
| 2022-01-12 01:18 | 2022-01-10 | RMD | RESMED INC | Sandercock Brett | Officer | OPT+S | $235.00 | 2,500 | $587,500 | 106,354 |
| 2022-01-11 00:19 | 2022-01-06 | TTOO | T2 Biosystems, Inc. | Ahuja Aparna | Officer | SELL | $0.48 | 61,988 | $29,754 | 107,611 |
| 2022-01-08 02:37 | 2022-01-05 | CMXC | Stimcell Energetics Inc. | HARGREAVES BRADLEY S | Director, Officer, 10% owner | SELL | $0.15 | 7,500 | $1,115 | 5,489,247 |
| 2022-01-08 00:15 | 2022-01-05 | PODD | INSULET CORP | Petrovic Shacey | Director, Officer | OPT+S | $264.97 | 15,000 | $3,974,550 | 17,249 |
| 2022-01-07 00:15 | 2022-01-04 | INSP | Inspire Medical Systems, Inc. | Ban Randy | Officer | OPT+S | $241.60 | 10,307 | $2,490,174 | 266 |
| 2022-01-05 17:16 | 2022-01-04 | DYNT | DYNATRONICS CORP | Provco Ventures 1 LP | 10% owner | BUY | $0.00 | 37,552 | $0 | 1,087,082 |
| 2022-01-05 17:13 | 2022-01-04 | DYNT | DYNATRONICS CORP | Baker Brian D. | Director | BUY | $0.00 | 8,734 | $0 | 111,903 |
| 2022-01-06 00:52 | 2022-01-03 | NVCR | NovoCure Ltd | Burke William Patrick | Officer | OPT+S | $76.00 | 3,951 | $300,263 | 50,870 |
| 2022-01-06 04:57 | 2022-01-03 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Officer | OPT+S | $20.02 | 2,300 | $46,039 | 0 |
| 2022-01-05 17:14 | 2022-01-04 | DYNT | DYNATRONICS CORP | ENRIGHT ERIN S. | Director | BUY | $0.00 | 80,146 | $0 | 105,601 |
| 2022-01-05 17:16 | 2022-01-04 | DYNT | DYNATRONICS CORP | Ward R Scott | Director | BUY | $0.00 | 5,000 | $0 | 87,078 |
| 2022-01-06 00:33 | 2022-01-04 | BSX | BOSTON SCIENTIFIC CORP | Mirviss Jeffrey B. | Officer | SELL | $43.54 | 6,840 | $297,806 | 133,153 |
| 2022-01-05 17:15 | 2022-01-04 | DYNT | DYNATRONICS CORP | LARKIN BRIAN | Director | BUY | $0.00 | 3,734 | $0 | 0 |
| 2022-01-06 00:32 | 2022-01-04 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | SELL | $43.54 | 6,161 | $268,230 | 0 |
| 2022-01-06 03:12 | 2022-01-03 | TNDM | TANDEM DIABETES CARE INC | BERGER DAVID B | Officer | OPT+S | $149.16 | 1,000 | $149,163 | 4,451 |
| 2022-01-06 03:46 | 2022-01-03 | PEN | Penumbra Inc | Sarna Surbhi | Director | SELL | $285.34 | 94 | $26,822 | 1,325 |
| 2022-01-06 03:41 | 2022-01-03 | PEN | Penumbra Inc | Roberts Johanna | Officer | OPT+S | $281.57 | 3,250 | $915,093 | 57,624 |
| 2022-01-06 03:37 | 2022-01-03 | PEN | Penumbra Inc | Grewal Harpreet | Director | SELL | $285.34 | 634 | $180,906 | 10,730 |
| 2022-01-06 03:34 | 2022-01-04 | PEN | Penumbra Inc | Wilder Thomas | Director | SELL | $283.99 | 80 | $22,719 | 54 |
| 2022-01-05 17:15 | 2022-01-04 | DYNT | DYNATRONICS CORP | KLOSTERMAN SCOTT | Director | BUY | $0.00 | 5,000 | $0 | 104,829 |
| 2022-01-05 17:15 | 2022-01-04 | DYNT | DYNATRONICS CORP | HOLTZ DAVID B | Director | BUY | $0.00 | 5,000 | $0 | 104,829 |
| 2022-01-05 17:14 | 2022-01-04 | DYNT | DYNATRONICS CORP | ESSIG STUART | 10% owner | BUY | $0.00 | 80,146 | $0 | 105,601 |
| 2022-01-06 03:24 | 2022-01-03 | CERS | CERUS CORP | Moore Carol | Officer | OPT+S | $7.00 | 19,059 | $133,417 | 181,276 |
| 2022-01-05 00:33 | 2022-01-03 | BSX | BOSTON SCIENTIFIC CORP | Olson Scott | Officer | SELL | $42.59 | 700 | $29,813 | 12,062 |
| 2022-01-04 19:43 | 2021-12-30 | ATAO | Premier Air Charter Holdings Inc. | Fourth Street Fund, LP | SELL | $0.03 | 3,300,000 | $89,100 | 244,293,050 | |
| 2022-01-05 05:24 | 2021-12-31 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, L.P. | BUY | $12.46 | 5,928 | $73,863 | 1,906,228 | |
| 2022-01-05 05:16 | 2021-12-30 | INFU | InfuSystem Holdings, Inc | Sheehan Jeannine | Officer | OPT+S | $17.01 | 7,943 | $135,100 | 17,607 |
| 2022-01-05 01:39 | 2022-01-04 | IRMD | IRADIMED CORP | Susi Roger E. | Director, Officer, 10% owner | SELL | $48.56 | 10,000 | $485,629 | 792,950 |
| 2022-01-05 02:12 | 2022-01-03 | RMD | RESMED INC | PENDARVIS DAVID | Officer | SELL | $258.52 | 1,544 | $399,155 | 116,035 |
| 2022-01-05 00:19 | 2021-12-31 | PODD | INSULET CORP | McMillan Wayde D. | Officer | SELL | $268.98 | 1,855 | $498,956 | 20,078 |
| 2022-01-03 14:11 | 2021-12-30 | GBS | INTELLIGENT BIO SOLUTIONS INC. | Parmakellis Tom | Director | BUY | $1.55 | 4,500 | $6,975 | 9,300 |
| 2022-01-04 00:15 | 2021-12-29 | XAIR | Beyond Air, Inc. | Lisi Steven A. | Director, Officer | SELL | $9.53 | 21,376 | $203,756 | 1,150,111 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.